In the present study, we observed that ERBB4 was highly expressed in endometrial cancer compared to normal endometrial tissue; thus, it may provide a clue for endometrial carcinogenesis and may serve as a novel target for treatment. This evidence concerns the gene ERBB4 and endometrial cancer.